Skip to main content
. Author manuscript; available in PMC: 2013 Jun 28.
Published in final edited form as: Cornea. 2012 Jun;31(6):662–667. doi: 10.1097/ICO.0b013e31823f8ae0

Table 1.

Organism, MIC, and outcome

Organism N Vori
cona
zole
Natamycin Voriconazole 3 week
BSCVA
(95% CI)**
3 month
BSCVA
(95% CI)**
3 week
infiltrate/
scar size
(95% CI)**
3 month
infiltrate/
scar size
(95%
CI)**
Perforation
(%)
Time to re-
epithelialization,
median, days
(95% CI)
MIC50
(μg/ml)
MIC90
*
(μg/ml)
MIC50
(μg/ml)
MIC90
*
(μg/ml)
Aspergillus
spp 1
17 7 32 32 1 1 0.80
(0.45, 1.15)
0.68
(0.29, 1.06)
4.50
(3.66, 5.33)
4.57
(3.67, 5.47)
4 (25%) 20.5 (11.5, NE***)
    A. flavus 11 6 32 32 1 1 0.85
(0.43, 1.26)
0.77
(0.31, 1.24)
4.62
(3.52, 5.71)
4.79
(3.62, 5.96)
2 (18%) 15 (4, NE)
A. fumigatus 5 0 4 8 0.5 0.5 0.85
(0.43, 1.26)
0.57
(−0.10, 1.24)
4.65
(3.55, 5.74)
4.55
(3.43, 5.67)
2 (40%) 20.5 (20.5, NE)
Fusarium spp 44 23 4 8 4 16 0.66
(0.42, 0.89)
0.40
(0.19, 0.61)
4.20
(3.64, 4.75)
4.00
(3.44, 4.57)
7 (16%) 14 (5, NE)
Bipolaris 6 4 4 4 0.5 8 0.28
(0.07, 0.48)
0.25
(0.09, 0.41)
2.99
(1.74, 4.24)
2.96
(1.93, 3.99)
2 (33%) 11.5 (4, NE)
Curvularia 8 4 4 256 0.5 2 0.64
(0.20, 1.08)
0.58
(0.03, 1.13)
3.34
(2.74, 4.19)
3.07
(2.42, 3.73)
0 (0%) 13.5 (4, NE)
Exserohilum 4 0 4 4 1 2 0.66
(0.43, 0.90)
0.51
(−0.47, 1.49)
3.88
(2.31, 5.44)
3.77
(1.57, 5.97)
0 (0%) 5 (4.5, NE)
Lasiodiplodia 3 3 4 32 2 4 0.68
(−0.14, 1.51)
0.70
(−0.13, 1.53)
4.69
(3.62, 5.75)
4.71
(3.58, 5.83)
0 (0%) 7 (7, NE)
Scedosporium 2 1 8 8 0.5 0.5 0.10
****
0.0 2.86 2.86 0 (0%) NE
P 0.21 <0.001 <0.001 0.84 0.82 0.55 0.39 0.60 0.73
Total 84 42 4 32 2 8 0.65 (0.49,
0.81)
0.48 (0.32,
0.63)
4.07
(3.69, 4.45)
3.96
(3.56, 4.35)
13 (15%) 15 (5, NE)
1

There was one Aspergillus terreus organism isolated

*

Highest value for organisms with fewer than 9 observations

**

95% confidence intervals estimated by accelerated bootstrap, 1000 resamplings. Infiltrate-scar size is the geometric mean of the largest scar diameter and the largest perpendicular, in mm. BSCVA is logMAR.

***

NE: Not estimable

****

Only 1 observation at 3 weeks and 3 months, no 95% CI